Jody S.  Lindell net worth and biography

Jody Lindell Biography and Net Worth

Director of Cooper Companies

Ms. Lindell is President and Chief Executive Officer of S.G. Management, Inc., an asset management company she has headed since 2000. Until May 2000, Ms. Lindell was a partner with KPMG LLP where she served as Partner-In-Charge of the Industrial Markets and Healthcare and Life Sciences practices for the Western Area. Ms. Lindell is also a Certified Public Accountant (inactive).

Ms. Lindell served as a director, and on the audit and director’s loan committees, for First Republic Bank, a publicly traded financial institution, until September 2007. First Republic Bank was acquired in 2007, underwent a management led buyout in mid-2010 and again became publicly traded (NYSE: FRC) in December 2010. Ms. Lindell continued to serve as a director for First Republic Bank through May 2017. She also served on the board of directors of PDL BioPharma (NasdaqGS: PDLI) from March 2009 through October 2018.

What is Jody S. Lindell's net worth?

The estimated net worth of Jody S. Lindell is at least $5.37 million as of January 6th, 2023. Ms. Lindell owns 54,172 shares of Cooper Companies stock worth more than $5,367,362 as of November 21st. This net worth approximation does not reflect any other investments that Ms. Lindell may own. Learn More about Jody S. Lindell's net worth.

How do I contact Jody S. Lindell?

The corporate mailing address for Ms. Lindell and other Cooper Companies executives is 6101 Bollinger Canyon Road Suite 500, San Ramon CA, 94583. Cooper Companies can also be reached via phone at (925) 460-3600 and via email at [email protected]. Learn More on Jody S. Lindell's contact information.

Has Jody S. Lindell been buying or selling shares of Cooper Companies?

Jody S. Lindell has not been actively trading shares of Cooper Companies during the last quarter. Most recently, Jody S. Lindell sold 4,000 shares of the business's stock in a transaction on Friday, January 6th. The shares were sold at an average price of $86.0750, for a transaction totalling $344,300.00. Following the completion of the sale, the director now directly owns 54,172 shares of the company's stock, valued at $4,662,854.90. Learn More on Jody S. Lindell's trading history.

Who are Cooper Companies' active insiders?

Cooper Companies' insider roster includes Brian Andrews (CFO), Robert Auerbach (CEO), Jody Lindell (Director), Daniel McBride (COO), Gary Petersmeyer (Director), Agostino Ricupati (SVP), Holly Sheffield (EVP), Gerard Warner, III (COO), Robert Weiss (Director), and Albert White, III (CEO). Learn More on Cooper Companies' active insiders.

Are insiders buying or selling shares of Cooper Companies?

In the last year, insiders at the medical device company sold shares 9 times. They sold a total of 631,377 shares worth more than $62,377,980.71. The most recent insider tranaction occured on September, 19th when CEO Albert G White III sold 114,992 shares worth more than $12,710,065.76. Insiders at Cooper Companies own 2.0% of the company. Learn More about insider trades at Cooper Companies.

Information on this page was last updated on 9/19/2024.

Jody S. Lindell Insider Trading History at Cooper Companies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/6/2023Sell4,000$86.08$344,300.0054,172View SEC Filing Icon  
4/4/2022Sell2,800$105.26$294,728.00View SEC Filing Icon  
7/2/2021Sell18,000$101.39$1,824,930.00View SEC Filing Icon  
9/16/2020Sell26,000$84.67$2,201,485.00View SEC Filing Icon  
1/6/2020Sell14,000$80.25$1,123,535.00View SEC Filing Icon  
6/24/2019Sell12,000$82.07$984,870.00View SEC Filing Icon  
4/1/2019Sell11,772$74.07$871,952.04View SEC Filing Icon  
3/14/2017Sell20,000$48.35$966,900.00View SEC Filing Icon  
3/7/2017Sell20,000$48.46$969,200.00View SEC Filing Icon  
9/9/2014Sell20,000$40.71$814,100.00View SEC Filing Icon  
See Full Table

Jody S. Lindell Buying and Selling Activity at Cooper Companies

This chart shows Jody S Lindell's buying and selling at Cooper Companies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cooper Companies Company Overview

Cooper Companies logo
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Read More

Today's Range

Now: $99.08
Low: $97.98
High: $99.19

50 Day Range

MA: $106.29
Low: $99.05
High: $111.23

2 Week Range

Now: $99.08
Low: $82.21
High: $112.38

Volume

898,934 shs

Average Volume

1,123,666 shs

Market Capitalization

$19.73 billion

P/E Ratio

55.20

Dividend Yield

N/A

Beta

0.99